搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
1 小时
on MSN
AstraZeneca's experimental drug disappoints in breast cancer survival trial
AstraZeneca said on Monday its experimental precision drug developed with Japan's Daiichi Sankyo did not significantly ...
23 分钟
AstraZeneca falls Monday, underperforms market
AstraZeneca PLC AZN shares dropped 1.66% to £115.84 Monday, on what proved to be an all-around great trading session for the ...
9 小时
on MSN
AstraZeneca's experimental cancer drug shows no significant improvement in overall survival
AstraZeneca said on Monday its experimental precision drug developed with Daiichi Sankyo did not significantly improve ...
9 小时
AstraZeneca drug fails to extend lives of breast cancer patients
A new AstraZeneca drug has failed to extend significantly the lives of breast cancer patients in a blow to the company’s ...
FierceBiotech
5 小时
AstraZeneca, Daiichi's Trodelvy rival fails to improve overall survival in breast cancer trial
AstraZeneca and Daiichi Sankyo’s TROP2-directed antibody-drug conjugate (ADC) has again failed to improve overall survival ...
41 分钟
Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In ...
Black Diamond Therapeutics reports promising initial Phase 2 data for BDTX-1535 in relapsed EGFR-mutant NSCLC patients. With ...
4 小时
Latest Trial Setback For AstraZeneca's Dato-DXd, The Drug Fails To Extend Lives Of ...
AstraZeneca released results from the TROPION-Breast01 Phase 3 trial of datopotamab deruxtecan, showing no statistically ...
Business Insider
11 小时
AstraZeneca’s Market Position and Drug Pipeline Sustain Buy Rating Despite TB01 Trial Results
J.P. Morgan analyst James Gordon has maintained their bullish stance on AZN stock, giving a Buy rating on September 20. James Gordon has given his Buy rating due to a combination of factors ...
17 天
中国拘留阿斯利康数名员工,涉未批准药物被带入中国
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber ...
9 小时
AstraZeneca: TROPION-Breast01 Phase III Trial Fails To Achieve Statistical Significance
AstraZeneca plc (AZN, AZN.L) announced on Monday that the high-level results from the TROPION-Breast01 Phase III trial of datopotamab ...
10 天
AstraZeneca董事长购买2,000股公司股票
AstraZeneca PLC (LSE:AZN) 今日宣布,公司非执行董事长Michel Demaré以每股117.927465英镑的价格购买了2,000股普通股。此次交易在伦敦证券交易所进行。 根据欧盟《市场滥用条例》的要求,Demaré的这次购买行为已被报告。这是一次简单的股票收购,没有其他需要报告的汇总交易。这种购买行为是上市公司管理层人员正常投资活动的一部分。
13 天
AstraZeneca-第一三共药物在非小细胞肺癌试验中显示生存趋势改善
特拉华州威尔明顿 - AstraZeneca和第一三共的datopotamab deruxtecan (Dato-DXd)在一项针对特定肺癌患者的III期试验中显示出相比化疗改善总生存期(OS)的趋势。这项名为TROPION-Lung01的研究涉及先前至少接受过一线治疗的局部晚期或转移性非鳞状非小细胞肺癌(NSCLC)成年患者。 在整体试验人群中,OS结果在数值上favored Dato-DXd优 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈